BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10886076)

  • 21. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis in bladder carcinomas detected with monoclonal antibody to single-stranded DNA: relation to cell cycle regulators and survival.
    Korkolopoulou P; Konstantinidou AE; Christodoulou P; Patsouris E; Thomas-Tsangli E; Kapralos P; Davaris P
    Urology; 2000 Sep; 56(3):516-20. PubMed ID: 10962336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
    Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of cyclin-dependent kinase inhibitor p27kip1 in node-positive breast cancer.
    Tsuchiya A; Zhang GJ; Kanno M
    J Surg Oncol; 1999 Apr; 70(4):230-4. PubMed ID: 10219018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.
    Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H
    J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
    Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M
    Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The expression of p53 and c-erb-2 in transitional cell carcinoma of the kidney pelvis and ureter and its relation to tumor progression and survival].
    Fontana LO; García García F; Arcas Martínez Salas I; García Ligero J; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Canteras Jordana M
    Arch Esp Urol; 2002 Sep; 55(7):792-6. PubMed ID: 12380307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
    Migita T; Oda Y; Naito S; Tsuneyoshi M
    Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
    Gillett CE; Smith P; Peters G; Lu X; Barnes DM
    J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
    Revelos K; Petraki C; Gregorakis A; Scorilas A; Papanastasiou P; Tenta R; Koutsilieris M
    In Vivo; 2005; 19(5):911-20. PubMed ID: 16097446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
    Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
    Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low levels of cell cycle inhibitor p27kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas.
    Lau R; Grimson R; Sansome C; Tornos C; Moll UM
    Int J Oncol; 2001 Jan; 18(1):17-23. PubMed ID: 11115534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prognostic Role of Ki-67/MIB-1 in Upper Urinary-Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis.
    Lei Y; Li Z; Qi L; Tong S; Li B; He W; Chen M
    J Endourol; 2015 Nov; 29(11):1302-8. PubMed ID: 26083161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of regulatory proteins and proliferative activity in relation to phenotypic characteristics of upper urothelial carcinoma.
    Dolićanin Z; Velicković LJ; Djordjević B; Visnjić M; Pesić I; Ristić A; Marjanović V
    Vojnosanit Pregl; 2011 Jul; 68(7):567-74. PubMed ID: 21899177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
    Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
    J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.
    Santos LL; Amaro T; Pereira SA; Lameiras CR; Lopes P; Bento MJ; Oliveira J; Criado B; Lopes CS
    Eur J Surg Oncol; 2003 Feb; 29(1):74-80. PubMed ID: 12559081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The prognostic value of KI-67 proliferation index in transitional cell carcinoma of renal pelvis and ureter].
    Korneev IA
    Vopr Onkol; 2005; 51(2):211-5. PubMed ID: 16223003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome.
    Sgambato A; Migaldi M; Faraglia B; De Aloysio G; Ferrari P; Ardito R; De Gaetani C; Capelli G; Cittadini A; Trentini GP
    Int J Cancer; 2002 Feb; 97(5):671-8. PubMed ID: 11807796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.